AYESHIA POWELL: Open Payments
NPI 1891164406 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,641 in 157 payments from 27 companies in 2025. Trend: 2023 $1,345 · 2024 $2,261 · 2025 $2,641
Food & beverage: $2,641
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $525 |
| UCB, Inc. | 14 | $266 |
| Otsuka America Pharmaceutical, Inc. | 20 | $245 |
| Lundbeck LLC | 12 | $240 |
| ARGENX US, INC. | 10 | $160 |
| Mallinckrodt Hospital Products Inc. | 5 | $125 |
| Neurelis, Inc. | 5 | $106 |
| SK Life Science, Inc. | 5 | $105 |
| Teva Pharmaceuticals USA, Inc. | 4 | $100 |
| ACADIA Pharmaceuticals Inc | 5 | $97 |
Products named: REXULTI, QULIPTA, VYEPTI, VYVGART HYTRULO, Rystiggo, UBRELVY, ACTHAR, VALTOCO.
Industry payments across GA — which companies pay providers there.
